CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- 4 Exercise or conversion President and CEO acquired 11,855 shares (option exercise)
- 4 Open-market sale Chief Operating Officer sold 6,250 shares at $39.43 ($246,438)
- 4 Open-market sale President and CEO sold 261,692 shares at an average $33.24 ($8,697,528)
- 4 Open-market sale Chief Operating Officer sold 12,500 shares at $29.43 ($367,875)
- 4 Open-market sale CFO, CBO sold 10,000 shares at $29.00 ($290,000)
- 4 Open-market sale President and CEO sold 116,901 shares at an average $28.69 ($3,354,384)
- 4 Open-market sale President and CEO sold 88,055 shares at an average $26.86 ($2,365,540)
- 4 Open-market sale CFO, CBO sold 10,000 shares at $26.00 ($260,000)
- 4 Open-market sale President and CEO sold 29,621 shares at an average $22.30 ($660,558)
- 4 Open-market sale CFO, CBO sold 10,000 shares at $23.00 ($230,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 75,335 shares at an average $22.02 ($1,658,527)
- 4 Open-market sale CFO, CBO sold 10,000 shares at $20.00 ($200,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 14 · 277 filings